Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$97.18 +1.47 (+1.54%)
As of: Sep 30, 2026 · 11:58 AM EDT

Rhythm Pharmaceuticals (RYTM) EBT Margin (2021 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) reported EBT Margin of -68.56% for Q2 2026, up 26.89 percentage points from -95.45% a year earlier and up 23.09 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) EBT Margin (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Rhythm Pharmaceuticals' EBT Margin came in at -85.14%, up 32.00 percentage points year-over-year; for FY2025, it was -103.31%, up 96.69 percentage points from FY2024.

  • EBT Margin has increased for four consecutive years, with a four-year change of +2103.79 percentage points (FY2021 to FY2025).
  • By year, EBT Margin came in at -200.00% in FY2024 (+37.78 pp), -237.79% in FY2023 (+528.43 pp), -766.22% in FY2022 (+1440.88 pp) and -2207.10% in FY2021.
  • The Q2 2026 figure ranks as the highest quarterly EBT Margin since Q1 2021.
  • Year over year, EBT Margin has now increased in each of the last nine quarters, with an average year-over-year change of +84.00 percentage points over the last eight quarters.
  • The high point for year-over-year EBT Margin in five years was Q2 2022 (a gain of 14253.64 percentage points); the low point was Q1 2022 (a drop of 191381.03 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -91.65% (Q1 2026), -83.03% (Q4 2025) and -102.91% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Rhythm Pharmaceuticals 6.78 Bn 5.65 Bn 62.32 Mn -68.56%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -68.56%
Mar 31, 2026 -91.65%
Dec 31, 2025 -83.03%
Sep 30, 2025 -102.91%
Jun 30, 2025 -95.45%
Mar 31, 2025 -151.11%
Dec 31, 2024 -103.71%
Sep 30, 2024 -132.28%
Jun 30, 2024 -109.30%
Mar 31, 2024 -543.27%
Dec 31, 2023 -170.99%
Sep 30, 2023 -194.61%
Jun 30, 2023 -242.98%
Mar 31, 2023 -454.96%
Dec 31, 2022 -483.42%
Sep 30, 2022 -953.80%
Jun 30, 2022 -494.90%
Mar 31, 2022 -3,506.74%
Dec 31, 2021 -2,798.84%
Sep 30, 2021 -4,290.08%
API Access

Rhythm Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=RYTM&period=max&api_key=YOUR_API_KEY